intranasal glutathione in parkinson& 39 Innovative approach Parkinson's targeting via berberine-loaded mucoadhesive surface-modified liposomes: a multi-faceted study | BMC Pharmacology and Toxicology Intranasal Delivery of Metabolically Resilient
Intranasal Delivery of Metabolically Resilient Glutathione: In Vivo Pharmacokinetic, Permeation, and Efficacy Studies Molecular Pharmaceutics Neuroimaging and fluid biomarkers in Parkinson's disease in an era of targeted interventions Nature Communications Intranasal delivery of rotigotine to the brain for treating Parkinson's disease ScienceDirect Nanotechnology based advancements in Parkinson's therapy: Exploring animal models and clinical insights in neurodegenerative disorders ScienceDirect
Pay in 4 interest-free payments of $7.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16



